A Pilot Study of Prophylactic Liposomal Amphotericin B (Ambisome®) Followed by Micafungin (Mycamine®) For 100 Days to Prevent Invasive Mold Infections Following Allogeneic Stem Cell Transplantation in Pediatric Recipients